← Back to Search

Adductor Canal Block for Postoperative Pain

Phase 3
Waitlist Available
Research Sponsored by Loyola University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during post-surgical hospitalization
Awards & highlights

Study Summary

This trial compares two ways to reduce pain after knee surgery. It measures the level of pain and use of pain medication after surgery.

Eligible Conditions
  • Postoperative Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1, 2, 4, 8, 12, 24, 36, and 48 hours after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1, 2, 4, 8, 12, 24, 36, and 48 hours after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Analgesic efficacy
Rescue narcotics use
Total narcotic consumption

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group AExperimental Treatment1 Intervention
Group A patients will receive their treatment at the completion of the case while under general anesthesia. The anesthesia provider will identify the adductor canal using ultrasound guidance and inject 15ccs of 0.5% marcaine with epinephrine around the saphenous nerve. Group A patients will receive placebo intra-articular and arthroscopic portal site saline injections equal in volume and procedure time point as the treatment in Group B. At the completion of the case, the patient will be extubated and transferred to the PACU.
Group II: Group BActive Control1 Intervention
Group B will receive 20ccs of 2% lidocaine with epinephrine as an intra-articular injection. At the completion of the arthroscopic procedure the patient will receive an additional 20ccs of 0.5% marcaine with epinephrine intra-articular injection. Group B patients will also receive 10ccs of 2% lidocaine with epinephrine injected superficially into each of the arthroscopic portal sites. Group B patients will receive a 15cc saline injection around the saphenous nerve under the same procedure as the adductor canal block for Group A. At the completion of the case, the patient will be extubated and transferred to the PACU.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Adductor Canal Block
2016
Completed Phase 4
~870

Find a Location

Who is running the clinical trial?

Loyola UniversityLead Sponsor
156 Previous Clinical Trials
30,834 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the Adductor Canal Block been cleared by the FDA?

"There is some evidence to support the efficacy of Adductor Canal Block, as this is a Phase 3 trial. Furthermore, because there have been multiple rounds of data supporting safety, our team rates the safety as a 3."

Answered by AI

Does this research project include any elderly participants?

"The age requirement for this clinical trial is that patients must be over 18 but younger than 65."

Answered by AI

If I wanted to participate in this research, what would I need to do?

"This study is currently recruiting postoperative pain patients that are between 18 and 65 years old. If you fit this criteria and would like to participate, please note that the investigators are looking for a total of 100 patients."

Answered by AI

Are there any open spots left for participants in this experiment?

"No, this study is not currently seeking patients for clinical trials. Although the study was last edited on April 11th, 2022, it is not actively recruiting. There are, however, 914 other trials that are actively recruiting patients."

Answered by AI
~11 spots leftby Apr 2025